ClinChoice
ClinChoice is a global company providing full-service Phase I-IV solutions to accelerate the market entry of life-changing products, with expertise in over 30 therapeutic areas and a wide range of clinical, regulatory, and safety services.
Services
ClinChoice provides a comprehensive range of services to expedite the approval process for life-changing products. These services include Phase I-IV clinical operations, biometrics solutions like biostatistics and data management, drug safety solutions, medical device safety, regulatory affairs, and medical writing services. Additionally, ClinChoice offers technology and medical affairs solutions to support post-approval regulatory requirements and medical communication needs.
Therapeutic Areas
ClinChoice has expertise in over 30 therapeutic areas. These areas include anti-infective, autoimmune diseases, COVID-19, metabolic, musculoskeletal, neurology, oncology, ophthalmology, rare disease, respiratory, and urology. Their broad expertise allows for specialized and targeted approaches to clinical trials across various medical fields.
Global Presence
ClinChoice operates on a global scale with offices located in the USA, China, Japan, India, Armenia, the United Kingdom, and the Philippines. This international footprint enables ClinChoice to conduct clinical trials and regulatory affairs in multiple jurisdictions, ensuring a broad reach and compliance with regional regulations.
Industry Partnerships
ClinChoice collaborates with industry-leading technology solution providers to enhance their service offerings. Partners include Anju, Calyx, Medidata, Oracle Health Sciences, OpenClinica, SAS Institute, and Veeva. These partnerships contribute to the advanced technology solutions provided by ClinChoice, supporting application management, implementation, upgrades, and business accelerator development.
Experience and History
With over 25 years of experience, ClinChoice has been facilitating the acceleration of drug and medical device approvals to market. Their extensive history and experience in early development, Phase II-IV clinical trials, and real-world evidence underscore their capability to deliver efficient and comprehensive solutions across diverse product types including vaccines, medical devices, consumer products, and natural products.